USPTO serial 99041690
TOUCHLIGHT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 24, 2026
- Examiner
- KEAM, ALEX S
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TOUCHLIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, enzymes, nucleic acid constructs and viral vectors for scientific and research use; nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; nucleic acid constructs and viral vectors for manufacturing viruses; nucleic acid constructs and viral vectors for use in scientific research, agribiotechnology, and nanotechnology; two-dimensional and three-dimensional nucleic acid constructs for creating nanostructures and scaffolds; all of the aforementioned goods not for medical or veterinary use | ACTIVE | — |
| 005 | Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for medical use; nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and viral vectors for gene therapy; nucleic acid constructs and viral vectors for use in cell therapy; nucleic acid constructs and viral vectors for use in genome editing; nucleic acid constructs and viral vectors for use in therapy | ACTIVE | — |
| 009 | Apparatus and instruments for the manufacture and processing of nucleic acid constructs, namely, DNA amplification apparatus and instruments for scientific and research purposes; nucleic acid constructs comprising natural and unnatural nucleotides, namely, nucleic acid amplification apparatus for scientific purposes; nucleic acid constructs comprising synthetic backbones or a mixture of natural and synthetic backbones, namely, nucleic acid amplification apparatus for scientific purposes; composites of nucleic acid constructs with organic and inorganic chemicals, namely, nucleic acid amplification apparatus for scientific purposes; all the aforesaid goods for use in nanotechnology applications including data storage, data retrieval and computing; electronic components in the form of electrical wires, semi-conductors, transistors, rectifiers, diodes, light emitting diodes (LEDs), and systems for energy storage, namely, batteries, all containing nucleic acid constructs; apparatus that uses nucleic acid constructs for labeling, imaging, and sensing applications for scientific research purposes; nucleic acid constructs as smart materials, being components of devices used for labeling, imaging and sensing DNA sequences for scientific research purposes; replacement parts for all the aforesaid technology | ACTIVE | — |
| 040 | Treatment of nucleic acid constructs; manufacture for others of nucleic acid constructs; manufacture for others of nucleic acids; manufacture for others of viruses; manufacture for others of vectors; manufacture for others of medical and veterinary therapies, vaccines, prophylactics, and counteragents; manufacture for others of nucleic acid constructs for nanotechnology applications; manufacture for others of nucleic acid constructs for labeling, imaging, and sensing applications; manufacture for others of nucleic acid constructs for electronic components; consultancy relating to the custom manufacture of the aforementioned goods | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of chemicals, enzymes, nucleic acid constructs, and viral vectors; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design, and development relating to therapies, prophylactics, and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy, diagnostic preparation, agribiotechnology, and nanotechnology; consultancy relating to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Touchlight IP Limited
- Other trademarks owned by Touchlight IP Limited
- Other trademarks owned by Touchlight IP Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named TOUCHLIGHT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 24, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 6, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 6, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 31, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 8, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 8, 2025 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Dec 8, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 8, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 8, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 8, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 21, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 21, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 21, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 20, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 20, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 20, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 29, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 25, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 25, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 14, 2025 | NWAP | NEW APPLICATION ENTERED | — |